Company / EPS (Basic)
Terns Pharmaceuticals, Inc. EPS (Basic) History
FY2021-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
-$1.12
FY2024
5-year range
-$2.21 / -$1.12
FY2021-FY2024
Trend
+11.8%
vs FY2023
Sector context
#98 of 207
Health Care
What the data says
At $-1.12, Terns Pharmaceuticals, Inc.'s eps (basic) ranks #98 of 207 in the Health Care sector. EPS (Basic) has increased for 3 consecutive years, from $-2.21 in FY2021 to $-1.12 in FY2024.
Based on SEC 10-K filings.
-1.12 in FY2024.
Improved from $-1.67 to $-1.12 over the past 2 years.
Health Care sector context is included.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#98 of 207 in Health CareTop 47% of 207This company -$1.12 Sector average -$0.42
▼
-167.4% below sector average
Key checks
Key Insights
- Terns Pharmaceuticals, Inc.'s eps (basic) has grown for 3 consecutive years.
- In FY2024, eps (basic) increased 11.8% year-over-year.
- Ranks #98 out of 207 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 7.86 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$1.12 | +11.8% |
| FY2023 | -$1.27 | +24.0% |
| FY2022 | -$1.67 | +24.4% |
| FY2021 | -$2.21 | - |
| FY2020 | - | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026